9176 Investors following Cadila Health. Share this News with them.
0
Like this story, share it with millions of investors on M3
Cadila Q1 net profit seen down at Rs 95.5 cr: Religare
Religare Hichens Harrison Research has come out with its earning estimates on Pharmaceutical Sector for the quarter ended June 2009. According to the research firm, Cadila's June quarter sales are expected to go up by 11.4% to Rs 795.7 crore on YoY basis.
Religare Hichens Harrison Research has come out with its earning estimates on Pharmaceutical Sector for the quarter ended June 2009. According to the research firm, Cadila 's June quarter sales are expected to go up by 11.4% to Rs 795.7 crore on YoY basis.
The company's net profit is expected to go down by 7.1% to Rs 95.5 crore on YoY basis.